A5006852984- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Renal cell carcinoma treatment
- Urological Disorders and Treatments
- Testicular diseases and treatments
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Ureteral procedures and complications
- Stoma care and complications
- Colorectal Cancer Surgical Treatments
- Urologic and reproductive health conditions
- Esophageal Cancer Research and Treatment
- Renal and Vascular Pathologies
- Pediatric Urology and Nephrology Studies
- Urinary Bladder and Prostate Research
- Sarcoma Diagnosis and Treatment
- Hernia repair and management
- Enhanced Recovery After Surgery
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Renal Transplantation Outcomes and Treatments
- Anorectal Disease Treatments and Outcomes
- Renal and related cancers
- Genital Health and Disease
- Epigenetics and DNA Methylation
University of Southern California
2019-2025
Duke University
2024-2025
Duke Medical Center
2025
Duke University Hospital
2025
USC Norris Comprehensive Cancer Center
2020-2024
Southern California University for Professional Studies
2019-2024
Sorbonne Université
2022
Keck Hospital of USC
2021
Mashhad University of Medical Sciences
2012-2019
Islamic Azad University, Mashhad
2018
Purpose: To compare the outcomes of robotic radical nephroureterectomy (RRNU) and laparoscopic (LRNU) within a large multi-institutional worldwide dataset. Materials Methods: The ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) includes data from 17 centers regarding 877 RRNU LRNU performed between 2015 2019. Baseline features, perioperative oncologic outcomes, were included. A 2:1 nearest-neighbor propensity-score matching with 0.001 caliper was performed. univariable...
We explored the accuracy of a urine-based epigenetic test for detecting upper tract urothelial carcinoma.Under an Institutional Review Board-approved protocol, urine samples were prospectively collected from primary carcinoma patients before radical nephroureterectomy, ureterectomy, or ureteroscopy between December 2019 and March 2022. Samples analyzed with Bladder CARE, that measures methylation levels 3 cancer biomarkers (TRNA-Cys, SIM2, NKX1-1) 2 internal control loci using...
We assessed the effect of prophylactic biologic mesh on parastomal hernia (PSH) development in patients undergoing cystectomy and ileal conduit (IC).
No AccessJournal of UrologyAdult Urology1 Jun 2013A Novel Method for Iatrogenic Vesicovaginal Fistula Treatment: Autologous Platelet Rich Plasma Injection and Fibrin Glue Interposition Maliheh Keshvari Shirvan, Daryoush Hamidi Alamdari, Alireza Ghoreifi ShirvanMaliheh Shirvan Department Urology, Imam Reza Academic Hospital, Mashhad University Medical Sciences, Mashhad, Iran , AlamdariDaryoush Alamdari Stem Cell Regenerative Medicine Research Group, Biochemistry, School Medicine,...
Intravesical recurrence (IVR) after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) has an incidence of approximately 20%-50%. Studies to date have been composed mixed treatment cohorts-open, laparoscopic and robotic. The objective this study is assess clinicopathological risk factors intravesical RNU UTUC in a completely minimally invasive cohort.We performed multicenter, retrospective analysis 485 patients with without prior or concurrent bladder cancer who...
Several reports are available regarding the treatment decision regret of patients receiving conventional treatments for localized prostate cancer (PCa); yet data on undergoing focal therapy (FT) sparse.To evaluate satisfaction and among who underwent FT PCa with high-intensity focused ultrasound (HIFU) or cryoablation (CRYO).We identified consecutive HIFU CRYO as primary at three US institutions. A survey validated questionnaires, including five-question Decision Regret Scale (DRS),...
Objectives: To identify correlates of survival and perioperative outcomes upper tract urothelial carcinoma (UTUC) patients undergoing open (ORNU), laparoscopic (LRNU), robotic (RRNU) radical nephroureterectomy (RNU). Methods: We conducted a retrospective, multicenter study that included non-metastatic UTUC who underwent RNU between 1990–2020. Multiple imputation by chained equations was used to impute missing data. Patients were divided into three groups based on their surgical treatment...
686 Background: Blue-light cystoscopy (BLC) is an established procedure for use in the diagnosis and surveillance of patients with non-muscle-invasive bladder cancer (NMIBC). It associated improved detection rates compared to white light (WLC); however, limited data available regarding its role upstaging and/or upgrading when used alongside WLC. The aim this study assess incidence features undergoing risk-group migration implementation BLC. Methods: Using from prospective multi-institutional...
410 Background: Inflammasomes are multiprotein complexes that regulate inflammation-associated signaling pathways. Although inflammation plays a crucial role in cancer cell proliferation, the specific of inflammasomes prostate (PCa) remains underexplored. This study aims to elucidate expression inflammasome-related genes PCa and assess their association with clinical outcomes. Methods: De-identified transcriptome data from cohort 52,266 radical prostatectomy (RP) samples tested (2016-2024)...
Objectives: To report the outcomes of minimally invasive (MIS) nephrectomy following immune checkpoint inhibitor (ICI) therapy.
No AccessJournal of UrologyAdult Urology1 Aug 2022Outcomes Lymph Node Dissection in Nephroureterectomy the Treatment Upper Tract Urothelial Carcinoma: Analysis ROBUUST Registry Kevin Hakimi, Umberto Carbonara, Hooman Djaladat, Reza Mehrazin, Daniel Eun, Adam Reese, Mark L. Gonzalgo, Vitaly Margulis, Robert G. Uzzo, James Porter, Chandru P. Sundaram, Firas Abdollah, Alexandre Mottrie, Riccardo Tellini, Matteo Ferro, Arman Walia, Ava Saidian, Shady Soliman, Julia Yuan, Alessandro Veccia,...
Treatment options for the management of upper tract urothelial cancer are based on accurate staging. However, performance conventional cross-sectional imaging clinical lymph node staging (N-staging) remains poorly investigated. This study aims to evaluate diagnostic accuracy N-staging.This was a multicenter, retrospective, observational study. We included 865 nonmetastatic (M0) patients treated with curative intended surgery and dissection who had been staged before surgery. compared (c)...
Urothelial carcinomas (UCs) are a broad and heterogeneous group of malignancies, with the prevalence upper tract urothelial carcinoma (UTUC) being rare, accounting for only 5-10% total malignancies. There is need additional toolsets to assist current clinical paradigm care patients UTUC. As non-invasive tool discovery cancer-related biomarkers, liquid biopsy has potential represent complex process tumorigenesis metastasis. Herein, we show efficacy as source biomarkers detecting Using...